Warning: Undefined variable $sector_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1234

Warning: Undefined variable $base_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1245

Warning: Undefined variable $industry_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1247

Warning: Undefined variable $base_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1261

Warning: Undefined variable $page_highlight in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1348

Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in /var/www/html/macrotrends/public_html/production/master_chart_page.php on line 310
Neurogene Number of Employees 2013-2025 | NGNE | MacroTrends

Neurogene Number of Employees 2013-2025 | NGNE

Neurogene number of employees from 2013 to 2025. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Neurogene Number of Employees 2013-2025 | NGNE

Neurogene number of employees from 2013 to 2025. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$209.6B
Amgen (AMGN)$149.1B
Gilead Sciences (GILD)$130.2B
Vertex Pharmaceuticals (VRTX)$125.6B
Bristol Myers Squibb (BMY)$100.2B
CSL (CSLLY)$74.3B
GSK (GSK)$74.1B
Regeneron Pharmaceuticals (REGN)$61.6B
Argenex SE (ARGX)$36.2B
Alnylam Pharmaceuticals (ALNY)$30.5B
BioNTech SE (BNTX)$23.7B
BeiGene (ONC)$22.8B
Biogen (BIIB)$17.4B
Genmab (GMAB)$13.3B
Genmab (GNMSF)$13.3B
Insmed (INSM)$13.2B
BioMarin Pharmaceutical (BMRN)$11.3B
Illumina (ILMN)$11.3B
Incyte (INCY)$11.3B
Ascendis Pharma (ASND)$10.1B
Exelixis (EXEL)$10B
Swedish Orphan Biovitrum (BIOVF)$9.6B
Moderna (MRNA)$9.6B
QIAGEN (QGEN)$9B
Exact Sciences (EXAS)$7.7B
Bio-Techne Corp (TECH)$7.6B
Repligen (RGEN)$7.3B
Halozyme Therapeutics (HALO)$7.3B
Roivant Sciences (ROIV)$7.2B
Revolution Medicines (RVMD)$6.8B